Lupin gets USFDA nod for generic schizophrenia drug

Drug maker Lupin said it had received approval from the U.S. health regulator to market Lurasidone Hydrochloride tablets in the U.S. The firm can sell its product, which is a generic version of Sunovion Pharmaceuticals Inc.’s Latuda tablets, in strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg. The drug is indicated for conditions such as schizophrenia and bipolar

Source : https://www.thehindu.com/todays-paper/tp-business/lupin-gets-usfda-nod-for-generic-schizophrenia-drug/article25936038.ece

About ChinmayaIAS Academy - Current Affairs

Check Also

HUMAN DEVELOPMENT INDEX

CONTEXT: India ranked 131 among 189 countries on the Human Development Index (HDI) for 2019, …

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Free Updates to Crack the Exam!
Subscribe to our Newsletter for free daily updates